Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy

• 主要な著者: Kyle Wesselman, PharmD candidate, MA, BS (著者), Vincent Cavaliere, PharmD, MM, BCPP (著者), Rakesh Goyal, MD (著者), Eric Anderson, MD, MBA, FAPA (著者)
• フォーマット: 図書
• 出版事項: American Association of Psychiatric Pharmacists, 2024-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Hyperammonemia is a well-known adverse effect of valproate that can progress to a potentially fatal condition known as valproate-induced hyperammonemic encephalopathy (VHE). VHE is more common when valproate is used in combination therapy with other antiepileptic medications. A growing number of cas...